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Objective: To describe contemporary consumer perspectives about prostate cancer 
survivorship in order to inform the development of survivorship guidelines. 
Method: In a cross-sectional qualitative design, semi-structured interviews were undertaken 
with fifty prostate cancer support group leaders (50% response) across urban and 
rural/regional Australia. An interpretative phenomenological approach was applied to guide 
the identification of experiences and priorities of survivorship from participants. 
Results: Three themes were identified for informing the development of prostate cancer 
survivorship guidelines: (1) The Experience of Diagnosis and Treatment; (2) Priorities for 
Survivorship; and (3) Mechanisms for Support. Four priorities for prostate cancer 
survivorship were identified: delivering person and men-centred care; improving 
communication; improving care coordination; and facilitating access to care. Mechanisms for 
support were peer support; advocacy; prostate cancer specialist nurses; and communication 
training for health professionals. 
Conclusions: The lack of progress in changing prostate cancer survivorship outcomes for 
men will become increasingly problematic as this patient population group grows. Co-




Cancer is a disease that from ancient times has been associated with dread, fear and a 
search for a seemingly elusive cure. As researchers and clinicians searched to better 
understand cancer and find effective treatments civil society organisations, such as the 
American Cancer Society (ACS), formed to galvanise efforts and provide funds for medical 
research importantly bringing the lay voice in to the crusade against cancer.(1)  In the 1970s 
the language of cancer begins to change with Nixon’s ‘war’ against cancer, the National 
Cancer Act of 1971(2), and the ACS slogan “cancer is a word not a sentence”. It was not 
however until the 1980s that the concept of cancer survivorship emerged in the literature(3), 
and the idea that how a person survived after cancer was important finally came into focus in 
the clinical world.  In 1986 the National Coalition for Cancer Survivorship was founded by 
cancer survivors to advocate for all people affected by cancer, defining survivorship as 
extending from the time of diagnosis and for the balance of life, a definition now expanded to 
include family, friends and caregivers.(4) A decade later, the National Cancer Institute 
established the first Office of Cancer Survivorship with an overarching goal to improve the 
quality of survival of all individuals diagnosed with cancer and their families.(5)   
Importantly, cancer advocacy driven by cancer survivors preceded these institutions 
and forged national and global initiatives.  In 1952, Terese Lasser founded Reach to 
Recovery, a peer support program for women with breast cancer, as a response to her 
personal experience of lack of support after her mastectomy.(6)  This program was adopted 
by the American Cancer Society and then became global supported by the International 
Union Against Cancer with programs spread across the Asia-Pacific, North and South 
America, and Europe.(7) In Australia in the early 1990s a grass roots prostate cancer 
survivorship movement emerged in response to lack of support for men living with prostate 
cancer and perceptions of stigma and invisibility in the national health services agenda, later 
joining and forming the backbone of the Prostate Cancer Foundation of Australia (PCFA).(8) 
In sum, cancer survivors have been and continue to be driving forces in determining how 
their care should be delivered and what areas of focus are most important from their 
perspective.  
However, the voice of the cancer survivor is not routinely visible in survivorship care 
initiatives and guidelines, and services developed in the absence of a patient voice risk being 
inaccessible or irrelevant to the individuals they seek to serve.  This is a particular issue for 
patient groups who by virtue of their illness type or sociodemographic and cultural 
background may less likely to advocate on their own behalf. Mitigating this risk by actively 
engaging cancer survivors in the development and delivery of survivorship care initiatives is 
encapsulated in the concept of co-production. Shifting from the traditional bio-medical view 
of health care as a ‘product’ delivered by clinicians to passive patients, to health care as a 
‘service’ co-produced collaboratively between patients, clinicians and health care systems 
embeds a role for patients as actors in their own health care.(9-11) Applying this to cancer 
survivorship care should help ensure that the health system and professional response is 
responsive and relevant to the priorities of patients and their families.  
In contrast to co-production, clinical practice guidelines are most often built upon the 
highest level scientific evidence available, preferably systematic reviews and meta-analyses 
and randomised controlled trials, and incorporating expert consensus opinion.  
Problematically, patient or consumer involvement in such guidelines tends to be poor, with 
most organisations involved in guidelines production not requiring consumer input, and as 
few as one in five developing consumer versions of these scientific documents.(12) In the 
case of existing prostate cancer survivorship guidelines (13), it is not clearly stated what input 
was obtained from survivors, and indeed such consultation appears to have been absent. 
Further, gaps in evidence for these existing guidelines suggest further consideration of 
content is needed.(14) 
Accordingly, and to address this gap in knowledge, a nation-wide and in depth 
consultation process about survivorship priorities was undertaken with men previously 
treated for prostate cancer who were involved in community support, advocacy and education 
for prostate cancer survivors across both urban and rural settings.  
METHOD 
Study Design 
This study used a cross-sectional qualitative design involving semi-structured 
interviews with prostate cancer support group leaders. Consistent with the aim of the study, 
we employed an interpretative phenomenological approach to guide the identification of 
experiences and priorities of survivorship from participants. 
Participants 
Eligible participants were required to be able to speak and read English, provide 
informed consent, and be either men who had experienced a prostate cancer diagnosis or a 
partner of these men who were leaders of support groups endorsed by the PCFA. Participants 
were purposively sampled to include metropolitan and regional areas as well as groups for 
younger men, gay and bisexual men, men with advanced disease.  
 
Procedure 
The study was approved by the University of Southern Queensland’s ethics board 
(H18REA192). One hundred support group leaders affiliated with the PCFA were sent an 
email invitation to participate in a semi-structured telephone interview to obtain their 
perspectives on prostate cancer survivorship in the Australian context. Fifty support group 
leaders (50% response rate), expressed interest and consented to participate in the study. 
Following informed consent, interviews were scheduled and conducted between November 
2018 and January 2019 by two interviewers with experience in collecting qualitative data 
from cancer survivors. An interview protocol informed the conduct of interviews with 
probing techniques used to facilitate expansive or specific responses. Interviews ranged from 
22 minutes to 55 minutes with an average interview time of 34 minutes. Questioning included 
examples as follows:  
• Tell me about your experience as a support group leader 
• Define the experience of prostate cancer survivorship, from your perspective as a 
support group leader 
• What are the key prostate cancer survivorship issues facing your support group 
members?  
• What prostate cancer survivorship issues would you tell an audience of politicians, 
health professionals and everyday Australians to act on? 
Data Analysis 
Recorded interviews were transcribed verbatim by a professional transcriptionist. 
Demographic data were obtained via self‐report and analysed using descriptive statistics. 
Before coding, data familiarisation occurred by a process of reading the transcribed 
interviews, reflecting on field notes taken during interviews to assist in the interpretation of 
meaning, and re-listening to audio-recorded interviews to develop an understanding of 
participant experiences and perspectives. Data were then inductively analysed using open 
coding(15), categorised, and built into themes by five coders independently (NR,JD,SKC,LZ, 
LE). Coders were qualified in social and behavioural science (JD,SKC,LZ,LE) and nursing 
(NR,SKC) with 2 to 20 years of experience working in prostate cancer survivorship. Coders 
used Braun and Clarke’s approach to thematic analysis(16) to code data and identify themes. 
Two researchers (LZ,LE) created a preliminary coding schema by coding all transcripts. This 
coding scheme was further refined by a third researcher (NR) and finalised by additional 
team members (JD,SKC) with the description of saturated themes and sub-themes arrived at 
through coding, synthesis and discussion. Coding was undertaken using NVivo 12 (QSR 
International, 2018). Reporting of data conforms with Consolidated Criteria for Reporting 
Qualitative Studies (COREQ) guidelines.(17)  
RESULTS 
Demographics 
The participants were on average 71.8 years of age (SD=7.9; range 47.8-87.6). 
Average length of time since diagnosis was 9.9yrs (SD=5.1; range 2-20 years). Overall, 
participants had been performing their volunteer roles within the support group for 5.9 years 
(SD=3.6;range 1-18 years). The average size of the support groups was 84 members 
(SD=28.2;range 23-167) with 48 groups supporting both partners and their patients; 1 group 
for gay or bisexual men; and 1 for men with advanced prostate cancer. An equal proportion 
of participants living in either an urban (50%) or non-urban (50%) area.   
Themes 
Following data analysis, three themes emerged. These included: (1) the Experience of 
Diagnosis and Treatment; (2) Priorities for Survivorship; and (3) Mechanisms for Support. 
Within these themes were a series of sub-themes as outlined in Figure 1 and Supplementary 
File 1. 
Theme 1: The Experience of Diagnosis and Treatment 
Perceptions of prostate cancer survivorship were strongly characterised by 
participants’ experience of diagnosis and treatment with frequent reference to challenges 
including: (1) physical and psychosocial burdens; (2) financial distress; (3) loss of 
masculinity; (4) lack of information; (5) lack of access to services; (6) decisional uncertainty; 
and (7) feeling discounted. 
Participants referred to sustained physical and psychosocial burdens associated with 
prostate cancer and its treatment throughout the illness experience. They described the 
ongoing challenge of managing multiple cancer-related symptoms and side-effects including 
urinary incontinence, sexual dysfunction and bowel problems as well as treatment side-
effects such as muscle-wastage, hot flushes, sleep disturbance, fatigue, weight gain and 
shrinkage of genitalia. Additionally, men linked the physical effects of prostate cancer and its 
treatment with extensive and ongoing psychosocial burden such as depression; distress; 
cognitive impairment; fear of recurrence associated with ongoing PSA testing; social 
withdrawal due to the potential for embarrassment from symptoms such as urinary 
incontinence; and partner distress after their cancer diagnosis.  
The prostate cancer diagnosis and treatment also affected the ability of men to earn an 
income, with financial distress commonly described by participants. After diagnosis men 
reported the need to reduce work hours leading to lower income and financial stress. This 
situation was exacerbated by out-of-pocket healthcare expenditure and/or the cost of having 
to travel for treatment or move closer to treatment centres. Facing extensive changes to 
physical and psychological health, work status and typical social roles, men struggled with a 
loss of masculinity and felt that prostate cancer led to a “loss of identity” and “loss of 
control”.  
Against a context of high needs, participants sought personalised information and 
support, however, they faced both a lack of information about how to manage their cancer-
related problems and a lack of access to services to support them in their current situation. 
Additionally, men identified that care was often delivered by treating professionals who were 
“in their own little silos” resulting in specific problems not being referred or comprehensive 
follow-up care not being provided. Without the direction they needed, men reported feeling 
like “just another number” and referred to being “lost within the system”. In this context, 
being informed about a new diagnosis or worsening condition resulted in decisional 
uncertainty about how to address the challenges associated with treatment choices. 
Accordingly, they expressed a desire for “consistency of care” to help them navigate through 
the challenges of their prostate cancer survivorship experience and “regain a sense of 
dignity”, of “self” and of “control”. 
 With unmet needs and in the absence of adequate decision support, men reported 
feeling discounted as they made life-changing decisions with limited support. Subsequently, 
participants argued that prostate cancer survivors were a “forgotten” group and argued that 
the disease is “far less visible and far less supported despite having just as much, if not more 
impact on Australians, than breast cancer”. In addition, openly and socially discussing 
prostate cancer-related issues such as sexual dysfunction, genital shrinkage and urinary 
incontinence was seen as “taboo” due to social norms attached to discussing male symptoms 
of an intimate nature.  
Theme 2: Survivorship Priorities 
For participants, the challenges associated with prostate cancer diagnosis and 
treatment were linked with four priorities for addressing survivorship: (1) delivering person 
and men-centred care; (2) improving communication; (3) improving care coordination; and 
(4) facilitating access to care. 
As part of delivering person and men-centred care, participants identified four 
components for improving the experience of prostate cancer survivors: educating men about 
their prognosis and treatment options including side-effects; tailoring support for men at 
diagnosis and as their prognosis changes; regularly communicating with men about their 
disease; and developing a plan to support men throughout their survivorship experience. 
Participants called for health professionals to focus on men’s preferences for how they would 
prefer to receive care; in what ways their family/carers would be involved; what support they 
needed; and, which treatments they preferred. Additionally, men wanted a “full explanation” 
of which treatment and support options were available to them, their side-effects and the 
likely prognosis associated with each treatment. 
Participants stressed the importance of improving communication at all stages of the 
disease experience because of emotional distress, information overload, and insufficient time 
between being informed of their options and needing to choose treatments. When informed of 
their therapeutic options, some men felt they were not informed appropriately or supported to 
make a decision that was best for them. Some men reported bewilderment at being subjected 
to “information overload” and “forced” to think about treatments while they were still 
processing a major life event. Men called for the need to extend conversations beyond the 
physical symptoms of cancer and its treatment to a broader array of challenges they faced 
included psychological stressors, financial problems and relationship difficulties.  
Participants saw a need for improved access to care for prostate cancer survivors by 
providing a full range of interdisciplinary care to meet the full spectrum of men’s’ needs. 
Ongoing psychosocial issues among men with prostate cancer were linked with low access 
and availability of allied health services, such as psychologists and social workers for 
survivors. The importance of providing improved access to care was particularly emphasised 
as a means for addressing disparate survivorship outcomes for men in regional or 
socioeconomically disadvantaged areas.  
In addition to improving access, participants identified care coordination was as a 
priority. Required elements of care coordination included: regularly providing education on 
survivorship treatment options; documenting a survivorship care plan for every man; 
referring men to a comprehensive range of healthcare services to assess and treat survivorship 
needs; allocating a “care coordinator” to prostate cancer survivors; multidisciplinary 
communication to facilitate awareness and delivery of care tailored to men’s needs, and 
tailoring the inclusion of partners, carers and/or families in care planning to men’s 
preferences.   
 As an additional survivorship priority, participants spoke of the need for advocacy as 
a necessary step towards addressing inequalities in the way prostate cancer is perceived and 
supported in Australia. Challenging public misconceptions about the disease was a common 
topic with participants believing prostate cancer was poorly understood in the public setting. 
Participants therefore called for population-level awareness campaigns to inform people 
about the seriousness of prostate cancer, the importance of supporting men with the disease, 
and the need for men to “get tested”. By raising public awareness, participants hoped political 
support could be built leading to government-funded public health campaigns, increased 
funding for research, and achieving funding equity with women’s cancers.  
Theme 3: Support Mechanisms  
Participants identified several support mechanisms for improving the experience of diagnosis 
and treatment and addressing survivorship priorities including: (1) peer support; (2) 
advocacy; (3) prostate cancer specialist nurses; and (4) communication training for health 
professionals. 
The role of peer support groups in empowering men with the disease was seen as a vital 
initiative to men with prostate cancer. Participants emphasised the need to refer men to 
support groups to share their experience and learn from other men with prostate cancer. 
Participants argued that men coped with prostate cancer better when sharing and receiving 
ideas and practical advice about their illness experience. Additionally, improved partner and 
carer support was endorsed with the need to discuss relationship and social challenges 
associated with prostate cancer survivorship and learn how others have coped in similar 
situations 
The need for peer support and advocacy stemmed from a recognition that effectively 
engaging men was complex with marginalised populations seen to be particularly at risk. 
Therefore, appealing to men with prostate cancer individually was seen as an undertaking that 
required stronger community involvement. The need for men with prostate cancer to “feel 
comfortable” talking about their needs required a groundswell of community support. Men 
with prostate cancer were seen to be “poor patients” by participants as many were believed to 
be not proactive about their health and failed to comply with treatment or ask for support 
despite it being available. The need for “man-friendly” health education, health systems and 
communities were highlighted by participants as a key plank in improving health literacy, 
positive changes to health behaviours and subsequent improvements in survivorship 
outcomes. Participants also expressed concerns about vulnerable marginalised populations 
including men who are younger, indigenous, speak little or no English, live rurally, or are 
incarcerated. Improved health service design and mass-marketing campaigns were identified 
as strategies to increase health literacy in men with prostate cancer. The need for workplace 
health promotion programmes also emerged strongly during interviews as a key strategy 
towards improving the palatability of men talking about prostate cancer and creating a culture 
that facilitated men to cope with the disease. 
Participants also called for prostate cancer specialist nurses to coordinate care by 
acting as a link to multi-disciplinary care and community programs. Prostate cancer specialist 
nurse services were seen to be readily accessible to men who were reluctant to engage in the 
“hassle” of booking a specialist or general practitioner’s appointment and just “wanted 
someone available right then, who could point me in the right direction at the right time” to 
community-based care, services and support.  
 Building on the need for improved communication as a survivorship priority, 
participants called for communication training to be provided to health professionals to 
improve skills in supporting men. Clearer communication was also desired about the use of 
the PSA test both as a diagnostic indicator for prostate cancer and as part of survivorship 
assessment. Participants further identified the need to improve communication among 
specialists both in terms of conveying the implications of a prostate cancer diagnosis and the 
pros and cons of available treatments in an unbiased fashion.  
DISCUSSION 
This study is a key part of re-positioning consumers to the forefront of the co-
production of prostate cancer survivorship priorities. Of great concern, men identified 
physical and psychosocial burden that included decisional uncertainty, feeling discounted; 
financial distress; a loss of masculinity; and a lack of information and access to services.  The 
persistence of these problems despite decades of both descriptive and intervention research 
for men with prostate cancer speaks to a lack of translation of research into practice that is of 
great concern.(18-21)  Participants identified four prostate cancer survivorship priorities to 
guide health care planning and delivery: (1) delivering person and men-centred care; (2) 
improving communication by health professionals; (3) improving care coordination; and (4) 
facilitating access to care. They also identified ways in which consumers can be further 
engaged in co-producing survivorship care through involvement in the creation of “man-
friendly” or men-centred health education, health systems and communities.   
Men with prostate cancer in Australia have historically stepped in to provide 
community-based care when action by the health system lagged.(8) As health systems adjust 
and work to catch up there is a risk that this voice will be lost or overridden by the health 
professional perspective.  At the heart of co-production is the need to shift from traditional 
approaches that privilege the expertise and knowledge of clinicians and view health care as a 
‘product’ to be delivered, to health care as a ‘service’ co-produced by patients and clinicians 
as contributing partners.(10, 22) Traditional forms of encouraging consumer participation 
through ‘patient voice’ and ‘patient voice’ are important but not enough by themselves to 
challenge and change the dominant health system model.(11, 23) Achieving system-wide co-
production of health care delivery requires going beyond solely seeking ‘patient voice’ and 
facilitating ‘patient choice’, to actively positioning consumers as co-producers of health 
services and systems.(23, 24) 
As a grassroots voice for prostate cancer survivorship in Australia, support group 
leaders’ responses flag a failure of personalised care and care coordination. A recent review 
identified a lack of follow-up care as a key reason why men with prostate cancer are left with 
unmet needs.(25) This issue is made more problematic by the lack of review-based evidence 
for care coordination and surveillance for recurrence.(14) Notably, participants in the present 
study eschewed traditional viewpoints associated with men avoiding thinking about their 
disease or desiring engagement in their care.(26) By contrast participants expressed a desire 
to direct their survivorship experience and called for a system which included them, 
consulted with them and advocated broadly for them. 
LIMITATIONS 
Strengths of the current study include a well characterised sample each with a lived 
experience of prostate cancer across a range of timespans, such that these shared perspectives 
are a broad representation of the state of survivorship care in Australia. Additionally, these 
survivorship priorities likely have high ecological validity given the continuing involvement 
of support group leaders in the community of men with the disease, and their current personal 
involvement in, or discussion about men’s local experiences of care. Nevertheless, these 
perspectives may not match priorities for men with prostate cancer from low and middle 
income countries, or those with markedly different health systems to that in the present study. 
We were however able to recruit men from regional and rural Australia and this speaks to the 
consideration of the poorer disease outcomes that are prevalent in these geographic areas.(27)  
CLINICAL IMPLICATIONS 
The experience of prostate cancer remains characterised by loss and feelings of being 
discounted in the health system, with gaps in services that exacerbate the challenges of 
diagnosis and treatment. Men-centred survivorship care that includes effective care 
coordination, enhanced health professional communication, and improved access to services 
is needed to improve outcomes for men and their families.  
CONCLUSION 
In conclusion, men are very clear about the challenges they face after prostate cancer 
and what is needed to address these.  In Australia and elsewhere men with prostate cancer 
have demonstrated readiness to act on their own behalf, with our without health professional 
support.(8) A key challenge to co-production is the potential for clinicians to revert back to 
viewing health care as a product to be delivered and centrally controlled.(11, 22) Supporting 
consumers to actively co-produce guidelines to direct health care delivery is one important 
system-wide approach to help change health care culture. We strongly advocate for this 
approach to become standard practice in any initiatives that seek to meaningfully improve 
outcomes for people living with cancer. 
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